| Type I interferons produced by dendritic cells promote their phenotypic and functional activation M Montoya, G Schiavoni, F Mattei, I Gresser, F Belardelli, P Borrow, ... Blood, The Journal of the American Society of Hematology 99 (9), 3263-3271, 2002 | 666 | 2002 |
| IL-15 is expressed by dendritic cells in response to type I IFN, double-stranded RNA, or lipopolysaccharide and promotes dendritic cell activation F Mattei, G Schiavoni, F Belardelli, DF Tough The Journal of Immunology 167 (3), 1179-1187, 2001 | 578 | 2001 |
| Classification of current anticancer immunotherapies L Galluzzi, E Vacchelli, JM Bravo-San Pedro, A Buqué, L Senovilla, ... Oncotarget 5 (24), 12472, 2014 | 548 | 2014 |
| ICSBP Is Essential for the Development of Mouse Type I Interferon-producing Cells and for the Generation and Activation of CD8α+ Dendritic Cells G Schiavoni, F Mattei, P Sestili, P Borghi, M Venditti, HC Morse III, ... The Journal of experimental medicine 196 (11), 1415-1425, 2002 | 500 | 2002 |
| Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1 E Vacchelli, Y Ma, EE Baracco, A Sistigu, DP Enot, F Pietrocola, H Yang, ... Science 350 (6263), 972-978, 2015 | 431 | 2015 |
| Cyclophosphamide synergizes with type I interferons through systemic dendritic cell reactivation and induction of immunogenic tumor apoptosis G Schiavoni, A Sistigu, M Valentini, F Mattei, P Sestili, F Spadaro, ... Cancer research 71 (3), 768-778, 2011 | 384 | 2011 |
| Cyclophosphamide induces type I interferon and augments the number of CD44hi T lymphocytes in mice: implications for strategies of chemoimmunotherapy of … G Schiavoni, F Mattei, T Di Pucchio, SM Santini, L Bracci, F Belardelli, ... Blood, The Journal of the American Society of Hematology 95 (6), 2024-2030, 2000 | 240 | 2000 |
| Eosinophils: The unsung heroes in cancer? G Varricchi, MR Galdiero, S Loffredo, V Lucarini, G Marone, F Mattei, ... Oncoimmunology 7 (2), e1393134, 2018 | 227 | 2018 |
| The tumor microenvironment: a pitch for multiple players G Schiavoni, L Gabriele, F Mattei Frontiers in oncology 3, 90, 2013 | 170 | 2013 |
| IL-33 restricts tumor growth and inhibits pulmonary metastasis in melanoma-bearing mice through eosinophils V Lucarini, G Ziccheddu, I Macchia, V La Sorsa, F Peschiaroli, C Buccione, ... Oncoimmunology 6 (6), e1317420, 2017 | 168 | 2017 |
| Type I interferons as stimulators of DC-mediated cross-priming: impact on anti-tumor response G Schiavoni, F Mattei, L Gabriele Frontiers in immunology 4, 75041, 2013 | 163 | 2013 |
| Cross talk between cancer and immune cells: exploring complex dynamics in a microfluidic environment L Businaro, A De Ninno, G Schiavoni, V Lucarini, G Ciasca, A Gerardino, ... Lab on a Chip 13 (2), 229-239, 2013 | 159 | 2013 |
| Type I IFNs control antigen retention and survival of CD8α+ dendritic cells after uptake of tumor apoptotic cells leading to cross-priming S Lorenzi, F Mattei, A Sistigu, L Bracci, F Spadaro, M Sanchez, M Spada, ... The Journal of Immunology 186 (9), 5142-5150, 2011 | 150 | 2011 |
| ICSBP is critically involved in the normal development and trafficking of Langerhans cells and dermal dendritic cells G Schiavoni, F Mattei, P Borghi, P Sestili, M Venditti, HC Morse III, ... Blood 103 (6), 2221-2228, 2004 | 133 | 2004 |
| Acidic microenvironment plays a key role in human melanoma progression through a sustained exosome mediated transfer of clinically relevant metastatic molecules Z Boussadia, J Lamberti, F Mattei, E Pizzi, R Puglisi, C Zanetti, L Pasquini, ... Journal of Experimental & Clinical Cancer Research 37, 1-15, 2018 | 130 | 2018 |
| Cancer-driven dynamics of immune cells in a microfluidic environment E Agliari, E Biselli, A De Ninno, G Schiavoni, L Gabriele, A Gerardino, ... Scientific reports 4 (1), 6639, 2014 | 90 | 2014 |
| The pleiotropic immunomodulatory functions of IL-33 and its implications in tumor immunity C Afferni, C Buccione, S Andreone, MR Galdiero, G Varricchi, G Marone, ... Frontiers in immunology 9, 2601, 2018 | 88 | 2018 |
| Organs on chip approach: a tool to evaluate cancer-immune cells interactions E Biselli, E Agliari, A Barra, FR Bertani, A Gerardino, A De Ninno, ... Scientific reports 7 (1), 12737, 2017 | 80 | 2017 |
| Combining type i interferons and 5-aza-2′-deoxycitidine to improve anti-tumor response against melanoma V Lucarini, C Buccione, G Ziccheddu, F Peschiaroli, P Sestili, R Puglisi, ... Journal of Investigative Dermatology 137 (1), 159-169, 2017 | 76 | 2017 |
| IRF-8 controls melanoma progression by regulating the cross talk between cancer and immune cells within the tumor microenvironment F Mattei, G Schiavoni, P Sestili, F Spadaro, A Fragale, A Sistigu, ... Neoplasia 14 (12), 1223-IN43, 2012 | 63 | 2012 |
luca businaroScientist, Italian National Research Council, Institute of NanotechnologyVerified email at cnr.it
